Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-052221

President, R&D sold 8,000 shares at $22.43 ($179,440)

  • President, R&D acquired 8,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bergstrom Donald A President, R&D 2022-10-03 Option exercise +8,000 $4.12 $32,960 96,683 D: show line 1 in the form
Bergstrom Donald A President, R&D 2022-10-03 Sale −8,000 $22.43 $179,440 88,683 D: show line 2 in the form
Open-market sales · 8,000 sh · avg $22.43 · $179,440

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Bergstrom Donald A President, R&D 2022-10-03 Option exercise · Stock Option (Right to Buy) −8,000 101,456 D: show line 3 in the form
Loading xslF345X03/doc4.xml…